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Epidemiological studies indicate that sud-
den cardiac death is the cause of 20–159 
deaths per 100,000 residents per year in 
Europe and 84–200 deaths/100,000 resi-
dents/year in the United States. According 
to the current recommendations of cardi-
ological societies, patients with a histo-
ry of myocardial infarction and reduced 
ejection fraction (EF < 35 %) should be 
protected by cardioverter–defibrilla-
tor implantation. Impaired EF has been 
shown to be a marker of increased car-
diovascular mortality and sudden cardiac 
death [1, 2], but it has relatively low sen-
sitivity for detecting arrhythmia and sud-
den cardiac death risk [3].
The diagnosis of mechanical dyssyn-
chrony induced by the presence of in-
farction scar and/or conduction abnor-
malities in patients with an EF of < 35 % 
may be associated with a greater propen-
sity for inducing serious ventricular ar-
rhythmia [ventricular tachycardia (VT), 
ventricular fibrillation (VF)] and sudden 
cardiac death. The assessment of region-
al myocardial function using tissue Dop-
pler echocardiography (TDE) allows for 
noninvasive analysis of the regional me-
chanical dysfunction (LV mechanical dis-
persion). Therefore, the aim of this study 
was to evaluate mechanical dispersion as 
an echocardiographic predictor of VT/VF.
Patients and methods
The study group consisted of 47 consecu-
tive patients with cardiac resynchroniza-
tion therapy defibrillator (CRT-D) devic-
es implanted in the Department of Car-
diology, Congenital Heart Diseases and 
Electrotherapy, of the Silesian Center for 
Heart Diseases in Zabrze between 2008 
and 2009. All patients who were includ-
ed in the study met the criteria for CRT-
D implantation, had an EF of < 35 %, and 
were followed up for more than  3 years. 
The study population was divided into 
two groups: Group 1 (n = 29) comprised 
patients who had recorded episodes of 
arrhythmic events; group 2 (n = 18) com-
prised patients who did not have any reg-
istered arrhythmic events within 4 years 
after implantation.
Arrhythmic events were defined as 
ventricular arrhythmias that required ap-
propriate antitachycardia pacing or shock 
released by an implantable cardioverter–
defibrillator (ICD) and included both VF 
and sustained VT (sVT). All data on ar-
rhythmic events were reviewed retrospec-
tively by a physician experienced in clin-
ical pacing.
Echocardiography
An echocardiographic study including 
standard measurement and TDE was 
completed for each patient before device 
implantation using the Vivid 5 System 
(GE-Vingmed, GE Healthcare). Digital 
echocardiographic recordings were an-
alyzed retrospectively using ECHOPAC 
9.0 software (GE Healthcare). A quanti-
tative assessment of left ventricular (LV) 
regional deformation was based on the 
color tissue velocity recordings. In our 
study, global LV function parameters 
were calculated: LV end-diastolic diam-
eter (LVEDD), LV end-systolic diameter 
(LVESD), interventricular septum (IVS) 
thickness, LV posterior wall (LVPW) 
thickness, end-systolic volume (ESV), 
end-diastolic volume (EDV), as well as 
regional LV function parameters—strain 
parameters (time to peak strain and post-
systolic strain) and velocity parameters 
(time to onset velocity, time to peak veloc-
ity, and time to end of systole) (. Fig. 1). 
LVEF was assessed according to Simp-
son’s biplane method. Myocardial strain 
was calculated based on the color tis-
sue velocity data recorded in two-cham-
ber and four-chamber apical view. Sub-
sequently, longitudinal strain was quanti-
fied for each myocardial segment [4]. LV 
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mechanical dispersion was defined as the 
standard deviation of the time measured 
from the beginning of the QRS complex 
to peak longitudinal segmental strain.
Statistical analysis
Continuous parameters are expressed 
as means with standard deviations, cat-
egorical variables are presented as num-
bers and percentages. Comparative anal-
ysis between groups was performed us-
ing Student’s t test for continuous vari-
ables and the chi-square test, as appro-
priate, for dichotomous parameters. All p 
values less than  0.05 were considered sig-
nificant. The dispersion value with opti-
mal sensitivity and specificity was iden-




mic events were recorded in 29 patients 
(group 1), whereas 18 patients did not ex-
perience arrhythmia (group 2). Four pa-
tients of group 1 and two of group 2 re-
ceived a CRT-D for secondary prevention 
(13.79 vs. 11.11 %, p = 0.789). The clinical 
characteristics of the patients are present-
ed in . Table 1. There were no significant 
differences between groups according to 
age, sex, and body mass index. No sig-
nificant differences between groups were 
observed for ischemic diseases, chronic 
heart failure, arterial hypertension, hyper-
lipidemia, and atrial fibrillation. Patients 
suffering from cardiomyopathy predom-
inated in group  1 (79.31 % in group  1 
vs. 44.44 % in group 2, p = 0.014). There 
was no significant difference in QRS du-
ration, mean blood pressure, hemato-
crit, INR, and potassium level between 
the two groups. No significant differenc-
es between groups were observed regard-
ing the intake of beta-adrenergic block-
ing agents and angiotensin-converting 
enzyme inhibitors or angiotensin recep-
tor blockers.
The average time to event after im-
plantation was 345 ± 317  days. Echo-
cardiographic findings are presented in 
. Table 2. There were significant differ-
ences between groups  1 and 2 with re-
spect to the timing of mechanical disper-
sion: (99.14 ± 33.60 vs. 72.98 ± 19.70 ms, 
p = 0.002). However, there were no signif-
icant differences between groups in terms 
of other echocardiographic parameters.
Patients with ischemic heart failure
Among the analyzed patients, those with 
ischemic etiology (patients after myocar-
dial infarction and patients suffering from 
coronary artery disease or ischemic car-
diomyopathy) were selected and divid-
ed into two groups: group ISCH 1 com-
prising patients with VT/VF (n = 15) dur-
ing follow-up and group ISCH 2 compris-
ing patients without VT/VF events during 
follow-up (n = 14). The results and echo-
cardiographic characteristics for patients 
with heart failure of ischemic etiology are 
presented in . Table 3. The average time 
to event post-device implantation in this 
Fig. 1 8 Tissue Doppler echocardiography-based longitudinal strain curves derived from mid-inferior 
and mid-anterior segments in two-chamber view
 
Fig. 2 8 ROC curve for the ability of mechanical dispersion to identify arrhythmic events during a 
4-year follow-up in ischemic patients
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group was 289 ± 267 days. Mechanical dis-
persion was greater in patients with doc-
umented arrhythmic events (group ISCH 
1; 97.80 ± 30.06 vs. 74.15 ± 15.72  ms; 
p = 0.014).
ROC curve analysis
As presented in . Fig. 2, the cutoff value 
for mechanical dispersion of 76 ms pro-
vided 67 % specificity and 83 % sensitiv-
ity. Measurements of mechanical disper-
sion and global strain in ischemic patients 
add important information about the risk 
of sudden cardiac death apart from infor-
mation provided by the EF. In patients 
with a preserved or slightly reduced EF, 
mechanical dispersion above 76 ms iden-
tified ischemic patients with an increased 
risk of sudden cardiac death.
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Abstract
Background. Myocardial mechanical dys-
synchrony induced by the presence of postin-
farction scar and/or conduction abnormali-
ties in patients with a left ventricular ejection 
fraction (LVEF) of < 35 % may be associated 
with a greater propensity toward inducing 
serious ventricular arrhythmia [ventricular 
tachycardia (VT), ventricular fibrillation (VF)] 
and sudden cardiac death. The assessment 
of regional myocardial function using tissue 
Doppler echocardiography (TDE) allows for 
noninvasive analysis of regional mechanical 
dysfunction (LV mechanical dispersion).
Aim. The aim of this study was to evaluate 
the TDE-based mechanical dispersion as a po-
tential echocardiographic predictor of VT/VF.
Methods. The study group consisted of 47 
consecutive ambulatory patients with im-
planted cardiac resynchronization therapy–
defibrillator (CRT-D) devices who were divid-
ed into two groups: Group 1 (n = 29) com-
prised patients with recorded episodes of VT/
VF, in whom baseline TDE data were avail-
able, and group 2 (n = 18) comprised patients 
without registered VT/VF in the device mem-
ory within 4 years after implantation. LV me-
chanical dispersion was defined as the stan-
dard deviation of the time measured from 
the beginning of the QRS complex to the 
peak longitudinal strain in apical four-cham-
ber and two-chamber views. A retrospective 
quantitative assessment of LV regional defor-
mation was based on the color tissue veloci-
ty recordings.
Results. The average time to event after im-
plantation was 345 days. Patients with elec-
trical events demonstrated greater mechan-
ical dispersion: 99.14 ± 33.60 vs. 72.98 ± 
19.70, p = 0.002.
Conclusion. During the 4-year follow-up, pa-
tients with documented VT/VF were charac-
terized by significantly higher LV mechanical 
dispersion as compared with patients with-
out electrical events. Measurement of LV me-
chanical dispersion might be helpful in deter-
mining the risk of sudden cardiac death.
Keywords
Dilated cardiomyopathy · Sudden cardiac 
death · Implantable cardioverter–
defibrillator · Mechanical dyssynchrony · 
Ultrasound strain
LV mechanische Dispersion als Prädiktor ventrikulärer Arrhythmie bei Patienten 
mit fortgeschrittener systolischer Herzinsuffizienz. Eine Pilotstudie
Zusammenfassung
Hintergrund. Eine myokardiale mechani-
sche Dyssynchronie, die durch eine Narbe 
nach Infarkt und/oder Erregungsleitungs-
störungen bei Patienten mit linksventrikulä-
rer Ejektionsfraktion (LVEF) < 35 % induziert 
wird, kann mit einem höheren Risiko der In-
duktion schwerer ventrikulärer Arrhythmien 
(ventrikuläre Tachykardie, VT; Kammerflim-
mern) und plötzlichem Herztod einherge-
hen. Die Untersuchung der regionalen Myo-
kardfunktion mit der Gewebsdopplerecho-
kardiographie (TDE) ermöglicht die nichtin-
vasive Erkennung einer regionalen mecha-
nischen Dysfunktion (mechanische LV-Dis-
persion).
Ziel. Ziel der vorliegenden Studie war es, 
die TDE-basierte mechanische Dispersion als 
potenziellen echokardiographischen Prädik-
tor von VT/Kammerflimmern zu untersuchen.
Methoden. Die Studiengruppe bestand aus 
47 konsekutiven ambulanten Patienten mit 
implantiertem CRT-D (kardialer Resynchroni-
sationstherapie-Defibrillator), die in 2 Grup-
pen aufgeteilt wurden: Gruppe 1 (n = 29) – 
Patienten mit dokumentierten Episoden von 
VT/Kammerflimmern, bei denen Ausgangs-
TDE-Daten verfügbar waren, und Gruppe 2 
(n = 18) – Patienten ohne Registrierung von 
VT/Kammerflimmern im Gerätespeicher in-
nerhalb von 4 Jahren nach Implantation. 
Die mechanische LV-Dispersion wurde defi-
niert als Standardabweichung der gemesse-
nen Dauer vom Beginn des QRS-Komplexes 
bis zur größten longitudinalen Verformung 
im apikalen 4-Kammer-Blick und 2-Kammer-
Blick. Eine retrospektive quantitative Beurtei-
lung der regionalen LV-Verformung basier-
te auf der Dokumentation der Farb-Gewebe-
doppler-Geschwindigkeit.
Ergebnisse. Die durchschnittliche Dauer 
bis zu einem Ereignis nach Implantation be-
trug 345 Tage. Patienten mit elektrisch regis-
trierten Ereignissen wiesen eine höhere me-
chanische Dispersion auf (99,14 ± 33,60 vs. 
72,98 ± 19,70; p = 0,002).
Schlussfolgerung. Während der 4-jährigen 
Nachbeobachtungsphase wiesen die Patien - 
ten mit Dokumentation von VT/Kammerflim-
mern eine signifikant höhere mechanische 
LV-Dispersion auf als die Patienten ohne elek-
trisch registrierte Ereignisse. Die Messung der 
mechanischen LV-Dispersion könnte zur Er-
mittlung des Risikos für einen plötzlichen 
Herztod von Nutzen sein.
Schlüsselwörter
Dilatative Kardiomyopathie · Plötzlicher 
Herztod · ICD · Mechanische Dyssynchronie · 
Sonographische Verformung
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Discussion
The etiology of sudden cardiac death is 
multifactorial. Several risk factors have 
been identified, such as decreased LVEF, 
history of coronary artery disease, ciga-
rette smoking, hypertension, obesity, male 
sex, heart failure, ventricular arrhythmias, 
increased ventricular ectopy, diminished 
heart rate variability, baroreflex sensitivi-
ty, and heart rate profile during exercise 
[5]. Randomized clinical trials indicate 
that 84 % of sudden deaths are due to ven-
tricular tachyarrhythmias, while bradyar-
rhythmias were responsible for 16 % of 
sudden cardiac deaths. VF was the most 
common ventricular tachyarrhythmia, 
usually secondary to VT, whereas the rest 
of the arrhythmias were caused by torsade 
de pointes [6]. The best method to pre-
vent sudden cardiac death in high-risk 
patients is ICD. ICD reduces mortality in 
patients selected for primary prevention 
of SCD on the basis of reduced LVEF. 
ICD can prevent sudden cardiac death 
caused by bradyarrhythmias, torsade de 
pointes associated with congenital long-
QT syndrome (LQTS), and pause-depen-
dent VT [7]. An impaired EF (< 35 %) is 
the main indication for cardioverter–de-
fibrillator implantation in patients af-
ter myocardial infarction. Hypertrophic 
obstructive cardiomyopathy, long QT 
and Brugada syndromes, and idiopathic 
VF are additional indications. Although 
LVEF is still regarded as a good predic-
tor of ventricular arrhythmias [8, 9], it 
has several limitations in terms of pre-
dicting sudden cardiac death. In the Ore-
gon Sudden Unexpected Death Study, on-
ly 30 % of sudden cardiac death cases met 
the criteria; 65 % of patients, who had LV 
function measured before sudden cardiac 
death, did not have severe LV dysfunction 
[10]. Other clinical studies indicated that 
52 % patients with sudden cardiac death 
had some decrease in LV systolic func-
tion, while 30 % had severely decreased 
LV systolic function. Therefore, based on 
current LVEF guidelines for sudden car-
diac death prevention, only 30 % would 
have qualified as candidates for a prophy-
lactic ICD. Patients who had sudden car-
diac death and normal LVEF were more 
often female, younger, more likely to have 
a seizure disorder, and more likely to be 
taking antiepileptics compared with pa-
tients with decreased LVEF [11–16].
A variety of mechanisms in heart fail-
ure can lead to sudden cardiac death such 
as remodeling of the myocardium, altered 
neurohumoral signaling, slowed conduc-
tion, impaired repolarization, poor cou-
pling of myocardium, and delayed-paced 
ventricular activation. These factors make 
the myocardium susceptible to arrhyth-
mia triggers [17]. The presence of scar 
tissue in the myocardium after myocar-
dial infarction causes electrical heteroge-
neity, changes in expression of ion chan-
nels, delayed electrical conduction, a dis-
persed recovery of excitability, and dis-
persed electrical repolarization. Electro-
physiological testing could be an objective 
screening tool; however, it is invasive, ex-
pensive, and impractical. Therefore, there 
is a need for a sensitive tool for evaluating 
the risk of sudden cardiac death.
Electrical dispersion results in altered 
myocardial function. Regional and glob-
al myocardial function and timing can be 
evaluated by tissue Doppler imaging of 
Table 1 Clinical characteristics of study population
Group 1 patients with 
VT/VF during follow-up 
(n = 29)
Group 2 patients 
without VT/VF during 
follow-up (n = 18)
p
Age (years) 66.38 ± 8.81 68.50 ± 12.23 NS
Sex (M = 1) n (%) 24 (82 %) 12 (67 %) NS
BMI 28.02 ± 5.54 27.54 ± 4.26 NS
Ischemic etiology, n (%) 15 (52 %) 14 (78 %) NS
Arterial hypertension, n (%) 11 (38 %) 12 (67 %) NS
Cardiomyopathy, n (%) 23 (79 %) 8 (44 %) 0.014
DM total, n (%) 11 (38 %) 5 (28 %) NS
Hyperlipidemia, n (%) 7 (24 %) 5 (28 %) NS
Atrial fibrillation, n (%) 9 (31 %) 5 (28 %) NS
QRS duration (ms) 161.59 ± 32.34 179.94 ± 35.42 NS
Mean blood pressure (mmHg) 96.94 ± 10.10 100.97 ± 12.26 NS
K (mmol/l) 4.51 ± 0.49 4.44 ± 0.40 NS
Pre-implantation PCI, n (%) 10 (34 %) 6 (33 %) NS
Beta-blocker, n (%) 25 (86 %) 16 (89 %) NS
ACEI/ARB, n (%) 24 (83 %) 15 (83 %) NS
ACEI/ARB angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, BMI body mass index, DM 
diabetes mellitus, K potassium, NS not significant, PCI percutaneous coronary intervention, VF ventricular fibril-
lation, VT ventricular tachycardia
Table 2 Echocardiographic measurements in all patients
Group 1 patients with VT/
VF during follow-up (n = 29)
GR 2 patients without VT/VF 
during follow-up (n = 18)
p
Septal flash, n (%) 14 (48 %) 10 (56 %) NS
EF (%) 27.95 ± 10.68 28.87 ± 8.69 NS
ESV (ml) 191.71 ± 90.05 172.73 ± 73.52 NS
EDV (ml) 249.89 ± 108.69 215.46 ± 79.99 NS
LVES dimension (mm) 67.70 ± 12.43 67.67 ± 7.74 NS
LVED dimension (mm) 55.53 ± 16.38 54.67 ± 10.13 NS
IVSD (mm) 11.44 ± 5.12 10.33 ± 2.73 NS
IVSS (mm) 14.29 ± 5.70 14.17 ± 3.82 NS
LVPWD (mm) 10.50 ± 2.39 10.20 ± 1.48 NS
LVPWS (mm) 13.86 ± 4.04 13.40 ± 2.88 NS
Mechanical dispersion 
(ms)
99.14 ± 33.60 72.98 ± 19.70 0.002
EDV end-diastolic volume, EF ejection fraction, ESV end-systolic volume, IVSD interventricular septum diastolic 
diameter, IVSS interventricular septum systolic diameter, LVES left ventricular end systolic, LVED left ventricular 
end diastolic, LVPWD left ventricular posterior wall  diastolicdiameter, LVPWS left ventricular posterior wall 
systolic diameter, NS not significant
602 | Herz 7 · 2016
Original articles
strain [18]. Mechanical dispersion, which 
can be defined as heterogeneous contrac-
tion assessed by myocardial strain, is use-
ful for the noninvasive measurement of 
LV function and the timing of myocardi-
al contraction, and it may be a good pre-
dictor of arrhythmic episodes. Clinical tri-
als indicated mechanical dispersion to be 
a good tool for predicting VT/VF in pa-
tients with long QT syndrome [19]. More-
over, mechanical dispersion by myocardi-
al strain is related to episodes of ventric-
ular arrhythmia in patients with ARVC.
The concept of using ultrasound-based 
mechanical dyssynchrony as a marker of 
sudden cardiac death was introduced for 
the first time by Norwegian researchers 
[20]. The results of our study confirmed 
to some extent their findings that greater 
mechanical dispersion occurs in patients 
with documented severe ventricular ar-
rhythmias. Mechanical dispersion may 
become an important parameter for eval-
uating the risk of sudden cardiac death 
and the necessity for cardioverter–defi-
brillator implantation. Segmental con-
tractility disorders are the result of electri-
cal abnormalities that appear in the place 
of postinfarction scars. The asynchronous 
work of all segments causes hemodynam-
ic cardiac inefficiency, and therefor there 
is a need for ICD therapy. Measurement 
of mechanical dispersion might help to 
better select patients who will be at risk 
of severe ventricular arrhythmia and sud-
den cardiac death. This parameter may 
be useful in clinical work for selecting pa-
tients who are in need of better care so as 
to avoid sudden cardiac death.
Study limitations
It was a retrospective, pilot study cover-
ing a relatively small group of patients. 
Moreover, consecutive patients formed 
the study group, derived from a hospital 
database with complete digital echo and 
clinical data.
Conclusion
This study demonstrates that during a 
4-year follow-up, patients with docu-
mented VT/VF were characterized by sig-
nificantly higher LV mechanical disper-
sion compared with patients without 
electrical events. The measurement of 
LV mechanical dispersion might be help-
ful in determining the risk of sudden car-
diac death. The determination of LV me-
chanical dispersion in each individual pa-
tient could be helpful in selecting pa-
tients for ICD therapy. However, this new 
ultrasound-based parameter of mechan-
ical dispersion requires further validation 
in a bigger cohort of patients.
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Ein Score aus 7 Parametern, die bei der 
Entlassung eines Patienten einfach erhoben 
werden können, hat in einer internationalen 
Kohortenstudie die Wiederaufnahme von 
Patienten in den ersten 30 Tagen nach der 
Entlassung aus dem Krankenhaus gut vorher-
gesagt. Wiederaufnahmen ins Krankenhaus 
sind vor allem in den USA häufig, wo die 
Liegezeiten aus Kostengründen niedrig 
gehalten werden. Die Folge ist, dass etwa 
20 % der Patienten in den folgenden 30 Tagen 
erneut in der Klinik behandelt werden müssen, 
häufig mit vermeidbaren Komplikationen. 
Ein Team vom Inselspital in Bern hat nach 
einer Möglichkeit gesucht, Patienten mit 
drohender Wiederaufnahme bereits bei der 
Entlassung zu erkennen. Das Ergebnis war der 
HOSPITAL-Score, der anhand von sieben Labor-
werten oder Patienteneigenschaften eine 
Vorhersage ermöglichen soll. Diese Prädiktoren 
sind: tiefer Hämoglobin-Spiegel (H), Ent-
lassung aus der Onkologie (O), Hyponatriämie 
(S für Sodium), Intervention (P für Procedure), 
Notfalleintritt (IT für Index Type urgent), Anzahl 
der Hospitalisierungen (A für Admissions) im 
letzten Jahr sowie ein Aufenthalt von 5 Tagen 
oder mehr (L für Length). Das Ergebnis ist ein 
Score, der einen Wert von 0 bis 13 Punkten 
annehmen kann.
Der Score wurde jetzt an den Daten von 
117.065 Patienten validiert, die an 6 Kliniken in 
den USA sowie jeweils einer Klinik in Kanada, 
Israel und der Schweiz behandelt worden 
waren: Insgesamt 16.992 Patienten (14,5 %) 
wurden innerhalb von 30 Tagen erneut 
aufgenommen, bei 11.307 Patienten (9,7 %) 
wurde dies als vermeidbar eingestuft.
Wie die Wissenschaftler berichten, wurde das 
Risiko einer Wiedereinweisung bei 73.031 
Patienten (62 %) aufgrund eines HOSPITAL-
Scores von 0 bis 4 Punkten als gering 
eingestuft. Hier kam es bei 5,8 % zu einer 
vermeidbaren Wiederaufnahme. Bei 27.612 
Patienten (24 %) gingen die Autoren aufgrund 
eines HOSPITAL-Scores von 5 bis 6 Punkten von 
einem intermediärem Risiko aus. Die Rate der 
vermeidbaren Wiederaufnahmen betrug in 
dieser Gruppe 11,9 %. Bei den 16.244 Patienten 
(14 %) mit einem Score von 7 bis 13 Punkten 
und damit einem hohen Risiko kam es zu 
22,8 % zu einer Wiederaufnahme, also viermal 
häufiger als bei Patienten mit einem niedrigen 
Score. Der Score erzielte in der C-Statistik einen 
Wert von 0,72 (1 wäre eine sichere Vorher-
sage), der sich laut den Autoren durchaus mit 
anderen Scores messen lassen kann. Die zur 
Vorhersage des Schlaganfalls verwendeten 
CHADS2- und CHADS2-VASC-Scores erzielten 
einen Wert von 0,68.
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